The detection of POSTN by the immunohistochemical (IHC) staining of tumor lesions by anti-POSTN mAbs targeting the fasciclin domain, which can inhibit integrin-mediated cell migration in vitro, has also been reported [48]. This evidence concerns the gene POSTN and neoplasm.